Navigation Links
Using nanoparticles, in vivo gene therapy activates brain stem cells

Using customized nanoparticles that they developed, University at Buffalo scientists have for the first time delivered genes into the brains of living mice with an efficiency that is similar to, or better than, viral vectors and with no observable toxic effect, according to a paper published this week in Proceedings of the National Academy of Sciences.

The paper describes how the UB scientists used gene-nanoparticle complexes to activate adult brain stem/progenitor cells in vivo, demonstrating that it may be possible to "turn on" these otherwise idle cells as effective replacements for those destroyed by neurodegenerative diseases, such as Parkinson's.

In addition to delivering therapeutic genes to repair malfunctioning brain cells, the nanoparticles also provide promising models for studying the genetic mechanisms of brain disease.

"Until now, no non-viral technique has proven to be as effective as the viral vectors in vivo," said co-author Paras N. Prasad, Ph.D., executive director of the UB Institute for Lasers, Photonics and Biophotonics, SUNY Distinguished Professor in UB's Department of Chemistry and principal investigator of the institute's nanomedicine program. "This transition, from in vitro to in vivo, represents a dramatic leap forward in developing experimental, non-viral techniques to study brain biology and new therapies to address some of the most debilitating human diseases."

Viral vectors for gene therapy always carry with them the potential to revert back to wild-type, and some human trials have even resulted in fatalities.

As a result, new research focuses increasingly on non-viral vectors, which don't carry this risk.

Viral vectors can be produced only by specialists under rigidly controlled laboratory conditions. By contrast, the nanoparticles developed by the UB team can be synthesized easily in a matter of days by an experienced chemist.

The UB researchers make their nanoparticles from hy
'"/>

Source:University at Buffalo


Page: 1 2 3

Related biology news :

1. Research Using Mouse Models Reveals A Novel Key Player In The Initiation Of Colon Cancer
2. Rush Physicians Using Gene Therapy For Heart Patients With Moderate To Severe Chest Pains Who Do Not Benefit From Other Treatments
3. Researchers Closer To Helping Hearing-Impaired Using Stem Cells
4. Using computers and DNA to count bacteria
5. Using the genomic shortcut to predict bacterial behavior
6. Using natures most primitive anti-viral defense system to find new approaches to cancer research
7. Using dental X-rays to detect osteoporosis
8. Using brain scans, researchers find evidence for a two-stage model of human perceptual learning
9. Using nanomagnets to enhance medical imaging
10. Adding Radiation Therapy To Chemotherapy Improves Survival In Patients With High-risk Breast Cancer
11. Columbia research lifts major hurdle to gene therapy for cancer

Post Your Comments:
(Date:11/23/2009)... Hampshire microbiologist Louis Tisa has received ...ing of the actinorhizal plants, widespread woody p...ontaminated soils. , The United States Departme... of molecular, cellular and biomedical sciences, $...een the bacteria Frankia and Casuarina, an actinor...
(Date:11/23/2009)... , , , , , , , ... Dr Andrew Marshall, from the Environment Departme...ery of Kinyongia magomberae and his wider work i...re information. , , , , , ... , , , , , , A new species of chamel...
(Date:11/23/2009)...ector of the Interuniversity Professorship in Law ... University of the Basque Country. The Professorsh...r experts such as researchers in the fields of mol...thics. , The Interuniversity Professorship in La...sto and the Basque Country was created in 1993. Th...
Breaking Biology News(10 mins):UNH prof. receives nearly $500,000 to research environmentally significant plants 2New chameleon species discovered in East Africa 2New chameleon species discovered in East Africa 3Research and legislation should go hand in hand, as much as possible 2Stryker Announces Agreements To Acquire Assets 6148 1Stryker Announces Agreements To Acquire Assets 6148 2Stryker Announces Agreements To Acquire Assets 6148 3Transcept Pharmaceuticals to Present at Lazard Capital Markets Healthcare Conference on November 17 6146 1Sanofi aventis and Regeneron Expand Strategic Antibody Collaboration 6144 1Sanofi aventis and Regeneron Expand Strategic Antibody Collaboration 6144 2Sanofi aventis and Regeneron Expand Strategic Antibody Collaboration 6144 3Sanofi aventis and Regeneron Expand Strategic Antibody Collaboration 6144 4Sanofi aventis and Regeneron Expand Strategic Antibody Collaboration 6144 5Sanofi aventis and Regeneron Expand Strategic Antibody Collaboration 6144 6
...by a University of Houston professor will be featu... Summit Research Conference July 28. , Kurt L. Kra...istry at UH, will give a presentation at 11 a.m. o...." , Sponsored by the Nanotechnology Foundation o...or Texas natural science, engineering and medical ...
...have identified a previously unknown family of vir... for the plague especially efficient at killing it...trated that the use of the common roundworm is a v...pestis, the bacterium that causes plague. They als...d the worm is quite similar to what occurs in mamm...
...have identified a previously unknown family of vir... for the plague especially efficient at killing it...trated that the use of the common roundworm is a v...pestis, the bacterium that causes plague. They als...d the worm is quite similar to what occurs in mamm...
Other Biology News:Disease diagnosis, bioengineering covered at state nano summit 2New Look at DNA Hints at Origin of UV Damage 2New Look at DNA Hints at Origin of UV Damage 3New Look at DNA Hints at Origin of UV Damage 4Novel plague virulence factor identified 2Novel plague virulence factor identified 3Novel plague virulence factor identified 4
(Date:11/19/2009)..., BETHESDA, Md., Nov. 19 /PRNewswire-FirstCall/...vator in biotechnology for diabetes therapy, and a...ervices to food, supplement, biotechnology and pha...he previously reported $6.3 million registered dir...870 shares of its common stock and warrants to pur...
(Date:11/19/2009)...VERN, Pa. and WALTHAM, Mass., Nov. 19 /PRNewswire/... Resources find that the leading driver of antibio... broad-spectrum activity against gram-positive and...ganisms that can cause nosocomial pneumonia, surve...arily for agents that provide appropriate coverage...
(Date:11/19/2009)... Top LASIK surgeons and recognized refracti...LASIK Surgeons made brought their fellow surgeons ...rrection surgery, cataract surgery, and ophthalmol...Academy of Ophthalmology (AAO) annual meeting in S...r. Shachar Tauber, Dr. David Huang, MD, Dr. Randy ...
(Date:11/19/2009)... VIENNA, Austria, November 19 AFFi...on one product candidate at an unexpectedly early,...s planned to enter into,Phase II clinical trial ea...ely follows the completion of two Phase I trials w...d its fast decision on the first interim,analysis ...
Breaking Biology Technology:Spherix Announces the Closing of $6.3 Million Registered Direct Offering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 3Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 3Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 2Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 3Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 4Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 5Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 6Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 7Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 8Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 9AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 3
...e Board of,Directors of Shire plc (LSE: SHP) (NASD...al company, announces today that Michael Rosenblat...ctor with immediate effect., Dr Rosenblatt is the...n, Massachusetts. He was previously Professor of M...n senior research positions at the Beth,Israel Dea...
...,Pharmaceutical Inc. (Nasdaq and SWX: BMRN) announ...ical Officer of BioMarin, will present a,company u...ugged Conference,in Key Biscayne, Florida on Thurs...ties may access a live audio webcast of the presen...bsite, http://www.BMRN.com . A,replay of the pres...
...r,BioTherapeutics, Inc. (OTC Bulletin Board: CVBTE...rey Jr. to form Cardio Derma Clinical Partners,(CD...general partner, will,fund a minimum of $1,000,000...of CVBT,s wound healing drug candidate., "R&D Par...by some of,today,s biggest names in biotechnology ...
Other Biology Technology:Dr Michael Rosenblatt Appointed Non-Executive Director at Shire 2Dr Michael Rosenblatt Appointed Non-Executive Director at Shire 3Dr Michael Rosenblatt Appointed Non-Executive Director at Shire 4BioMarin to Present at the Morgan Stanley Healthcare Conference 2CardioVascular BioTherapeutics, Inc. Funding Wound Healing Trial with R&D Partnership 2CardioVascular BioTherapeutics, Inc. Funding Wound Healing Trial with R&D Partnership 3
Mouse Anti-p230 trans Golgi Monoclonal Antibody, Unconjugated, Clone 15 from BD Biosciences Pharmingen
...s intensely fluorescent and highly photostable Flu...use in a variety of applications requiring probes ...rotein- and other macromolecule-labeled microspher... bind to non-target surfaces in some applications....
DNA Polymerase I Large (Klenow) Fragment from Invitrogen
...chium album Description: Proteinase K is a high...range of applications purified from the fungus T. ...he carboxyl group of N-substituted hydrophobic ali...fied as a serine protease. Proteinase K is useful ...
Biology Products: